Cinnarizine 25 mg Tablets (Cinnaron®)
【Registration Number】024629
【Active Ingredient】Cinnarizine 25 mg
【Indication】
  • Cinnarizine 25 mg Tablets (Cinnaron®) is indicated for the symptomatic treatment of nausea and vomiting caused by Meniere's disease and other labyrinthine disorders and for the prevention and treatment of motion sickness.
  • Cinnarizine is also indicated for the long term management of symptoms of peripheral and cerebral vascular disorders such as intermittent claudication, rest pain, vascular cramps and vasopastic disorders, e.g. Raynaud's disease.
【Manufacturer】Remedica Ltd.
【Manufacturer Address】Aharnon Street, Limassol Industrial Estate, Limassol, 3056, Cyprus.
【Category】Prescription Drug